Utilizing antibiotics to prevent Clostridioides difficile infection: does exposure to a risk factor decrease risk? A systematic review

被引:4
作者
Carlson, Travis J. [1 ]
Gonzales-Luna, Anne J. [2 ]
机构
[1] High Point Univ, Fred Wilson Sch Pharm, Dept Clin Sci, One Univ Pkwy, High Point, NC 27268 USA
[2] Univ Houston, Coll Pharm, Dept Pharm Practice & Translat Res, 4849 Calhoun Rd, Houston, TX 77204 USA
关键词
ORAL VANCOMYCIN PROPHYLAXIS; EFFICACY; EPIDEMIOLOGY; FIDAXOMICIN; RECURRENCE; BURDEN;
D O I
10.1093/jac/dkaa251
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Antibiotic use is a major risk factor for Clostridioides difficile infection (CDI). However, antibiotics recommended for CDI treatment are being utilized in clinical practice as prophylactic agents. Objectives: To comprehensively summarize and critically evaluate the published literature investigating the effectiveness of antibiotic CDI prophylaxis. Methods: A systematic search for relevant literature was conducted in PubMed and ClinicalTrials.gov. Two investigators independently screened each article for inclusion, and the references of the included articles were studied to identify additional relevant articles. Data extraction and an assessment of risk of bias was completed for all included studies. Unadjusted risk ratios and 95% CI were calculated for each study, with CDI being the outcome variable and prophylaxis (prophylaxis versus control) representing the exposure. Results: In total, 13 articles were identified in PubMed and 9 ongoing or unpublished trials were identified in ClinicalTrials.gov. The effect of antibiotic prophylaxis on CDI rates varied between studies; however, most favoured the use of antibiotic prophylaxis. Conclusions: The authors of this review conclude that the current literature carries a high risk of bias and the results should be interpreted with caution.
引用
收藏
页码:2735 / 2742
页数:8
相关论文
共 36 条
  • [1] Multihospital Outbreak of Clostridium difficile Ribotype 027 Infection: Epidemiology and Analysis of Control Measures
    Aldeyab, Mamoon A.
    Devine, Michael J.
    Flanagan, Peter
    Mannion, Michael
    Craig, Avril
    Scott, Michael G.
    Harbarth, Stephan
    Vernaz, Nathalie
    Davies, Elizabeth
    Brazier, Jon S.
    Smyth, Brian
    McElnay, James C.
    Gilmore, Brendan F.
    Conlon, Geraldine
    Magee, Fidelma A.
    Elhajji, Feras W. Darwish
    Small, Shaunagh
    Edwards, Collette
    Funston, Chris
    Kearney, Mary P.
    [J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2011, 32 (03) : 210 - 219
  • [2] Risk of Clostridium difficile Infection with Systemic Antimicrobial Therapy Following Successful Fecal Microbiota Transplant: Should We Recommend Anti-Clostridium difficile Antibiotic Prophylaxis?
    Allegretti, Jessica R.
    Kao, Dina
    Phelps, Emmalee
    Roach, Brandi
    Smith, Justin
    Ganapini, Vincent C.
    Kassam, Zain
    Xu, Huiping
    Fischer, Monika
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2019, 64 (06) : 1668 - 1671
  • [3] Vancomycin prophylaxis for Clostridium difficile infection among lung transplant recipients
    Bajrovic, Valida
    Budev, Marie
    McCurry, Kenneth R.
    Brizendine, Kyle D.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2019, 38 (08) : 874 - 876
  • [4] Historical perspectives on studies of Clostridium difficile and C difficile infection
    Bartlett, John G.
    [J]. CLINICAL INFECTIOUS DISEASES, 2008, 46 : S4 - S11
  • [5] Efficacy of Secondary Prophylaxis With Vancomycin for Preventing Recurrent Clostridium difficile Infections
    Carignan, Alex
    Poulin, Sebastien
    Martin, Philippe
    labbe, Annie-Claude
    Valiquette, Louis
    Al-Bachari, Hamed
    Montpetit, Louis-Philippe
    Pepin, Jacques
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 (12) : 1834 - 1840
  • [6] Oral vancomycin prophylaxis during systemic antibiotic exposure to prevent Clostridiodes difficile infection relapses
    Caroff, Daniel A.
    Menchaca, John T.
    Zhang, Zilu
    Rhee, Chanu
    Calderwood, Michael S.
    Kubiak, David W.
    Yokoe, Deborah S.
    Klompas, Michael
    [J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2019, 40 (06) : 662 - 667
  • [7] Centers for Medicare and Medicaid Services, HOSP ACQ COND HAC RE
  • [8] Burden of Clostridium difficile on the Healthcare System
    Dubberke, Erik R.
    Olsen, Margaret A.
    [J]. CLINICAL INFECTIOUS DISEASES, 2012, 55 : S88 - S92
  • [9] Chemoprophylaxis of Clostridium difficile Infections in High-Risk Hospitalized Patients
    Dupont, Herbert L.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2014, 12 (11) : 1862 - 1864
  • [10] Effect of vancomycin on intestinal flora of patients who previously received antimicrobial therapy
    Edlund, C
    Barkholt, L
    OlssonLiljequist, B
    Nord, CE
    [J]. CLINICAL INFECTIOUS DISEASES, 1997, 25 (03) : 729 - 732